Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 52, Issue , 2014, Pages 24-27

  Wang, Huikun ^a   Lupica, Carl R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

CB1 receptor; Dopamine neuron; Endocannabinoid; Synaptic modulation; Ventral tegmental area

Indexed keywords

2 ARACHIDONOYLGLYCEROL; CANNABINOID 1 RECEPTOR; DOPAMINE; ENDOCANNABINOID;

ARTICLE; DOPAMINERGIC NERVE CELL; DRUG ABUSE; DRUG EXPOSURE; LIPID METABOLISM; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MOLECULAR INTERACTION; NERVE CELL PLASTICITY; PROTEIN SECRETION; REWARD; SENSORY NERVE; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM; ANIMAL; CYTOLOGY; DRUG EFFECTS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; DOPAMINE; DOPAMINERGIC NEURONS; ENDOCANNABINOIDS; HUMANS; NEURONAL PLASTICITY; RECEPTOR, CANNABINOID, CB1; REWARD; VENTRAL TEGMENTAL AREA;

EID: 84899620763     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.01.019     Document Type: Article

References (52)

1. Alger B.E. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 2002, 68:247-286.
2. Bisogno T., Sepe N., Melck D., Maurelli S., De P.L., Di M.V. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 1997, 322(Pt 2):671-677.
3. Carlson G., Wang Y., Alger B.E. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat Neurosci 2002, 5:723-724.
4. Cheer J.F., Wassum K.M., Sombers L.A., Heien M.L., Ariansen J.L., Aragona B.J., et al. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 2007, 27:791-795.
5. Chevaleyre V., Takahashi K.A., Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 2006, 29:37-76.
6. Cohen J.Y., Haesler S., Vong L., Lowell B.B., Uchida N. Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature 2012, 482:85-88.
7. Dana C., Vial M., Leonard K., Beauregard A., Kitabgi P., Vincent J.P., et al. Electron microscopic localization of neurotensin binding sites in the midbrain tegmentum of the rat. I. Ventral tegmental area and the interfascicular nucleus. J Neurosci 1989, 9:2247-2257.
8. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372:686-691.
9. Gardner E.L. Addiction and brain reward and antireward pathways. Adv Psychosom Med 2011, 30:22-60.
10. Gerdeman G.L., Lovinger D.M. Emerging roles for endocannabinoids in long-term synaptic plasticity. Br J Pharmacol 2003, 140:781-789.
11. Glimcher P.W. Understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis. Proc Natl Acad Sci U S A 2011, 108(Suppl. 3):15647-15654.
12. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 1988, 24:19-28.
13. Haj-Dahmane S., Shen R.Y. The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling. J Neurosci 2005, 25:896-905.
14. Haj-Dahmane S., Shen R.Y. Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons. J Physiol 2010, 588:2589-2604.
15. 2+ dependency for triggering retrograde endocannabinoid signal. Neuron 2005, 45:257-268.
16. Heifets B.D., Castillo P.E. Endocannabinoid signaling and long-term synaptic plasticity. Annu Rev Physiol 2009, 71:283-306.
17. Hokfelt T., Everitt B.J., Theodorsson-Norheim E., Goldstein M. Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J Comp Neurol 1984, 222:543-559.
18. Hyland B.I., Reynolds J.N., Hay J., Perk C.G., Miller R. Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 2002, 114:475-492.
19. Johnson S.W., Seutin V., North R.A. Burst firing in dopamine neurons induced by N-methyl-d-aspartate: role of electrogenic sodium pump. Science 1992, 258:665-667.
20. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 2009, 89:309-380.
21. Kim J., Isokawa M., Ledent C., Alger B.E. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 2002, 22:10182-10191.
22. Kitai S.T., Shepard P.D., Callaway J.C., Scroggs R. Afferent modulation of dopamine neuron firing patterns. Curr Opin Neurobiol 1999, 9:690-697.
23. Kortleven C., Bruneau L.C., Trudeau L.E. Neurotensin inhibits glutamate-mediated synaptic inputs onto ventral tegmental area dopamine neurons through the release of the endocannabinoid 2-AG. Neuropharmacology 2012, 63:983-991.
24. Kortleven C., Fasano C., Thibault D., Lacaille J.C., Trudeau L.E. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice. Eur J Neurosci 2011, 33:1751-1760.
25. Kreitzer A.C., Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 2001, 29:717-727.
26. Labouebe G., Liu S., Dias C., Zou H., Wong J.C., Karunakaran S., et al. Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat Neurosci 2013, 16:300-308.
27. Linsenbardt D.N., Boehm S.L. Agonism of the endocannabinoid system modulates binge-like alcohol intake in male C57BL/6J mice: involvement of the posterior ventral tegmental area. Neuroscience 2009, 164:424-434.
28. Lupica C.R., Riegel A.C. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 2005, 48:1105-1116.
29. Maejima T., Hashimoto K., Yoshida T., Aiba A., Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 2001, 31:463-475.
30. 2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum. J Neurosci 2005, 25:6826-6835.
31. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
32. Matyas F., Urban G.M., Watanabe M., Mackie K., Zimmer A., Freund T.F., et al. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 2008, 54:95-107.
33. Melis M., Perra S., Muntoni A.L., Pillolla G., Lutz B., Marsicano G., et al. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neurosci 2004, 24:10707-10715.
34. Melis M., Pistis M. Hub and switches: endocannabinoid signalling in midbrain dopamine neurons. Philos Trans R Soc Lond B Biol Sci 2012, 367:3276-3285.
35. Melis M., Pistis M., Perra S., Muntoni A.L., Pillolla G., Gessa G.L. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 2004, 24:53-62.
36. Ohno-Shosaku T., Maejima T., Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29:729-738.
37. Oleson E.B., Beckert M.V., Morra J.T., Lansink C.S., Cachope R., Abdullah R.A., et al. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron 2012, 73:360-373.
38. Pan B., Hillard C.J., Liu Q.S. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J Neurosci 2008, 28:14018-14030.
39. Pan B., Hillard C.J., Liu Q.S. Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J Neurosci 2008, 28:1385-1397.
40. Pan B., Zhong P., Sun D., Liu Q.S. Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects. J Neurosci 2011, 31:11244-11255.
41. Riegel A.C., Lupica C.R. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci 2004, 24:11070-11078.
42. Schultz W., Dayan P., Montague P.R. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
43. Seutin V., Johnson S.W., North R.A. Apamin increases NMDA-induced burst-firing of rat mesencephalic dopamine neurons. Brain Res 1993, 630:341-344.
44. Steinberg E.E., Keiflin R., Boivin J.R., Witten I.B., Deisseroth K., Janak P.H. A causal link between prediction errors, dopamine neurons and learning. Nat Neurosci 2013, 16:966-973.
45. Sugiura T., Kobayashi Y., Oka S., Waku K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids 2002, 66:173-192.
46. Szabo B., Siemes S., Wallmichrath I. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci 2002, 15:2057-2061.
47. Ueda N., Tsuboi K., Uyama T., Ohnishi T. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol. Biofactors 2011, 37:1-7.
48. Ward C.W., Lawrence M.C. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Bioessays 2009, 31:422-434.
49. Wilson R.I., Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 2001, 410:588-592.
50. Wilson R.I., Nicoll R.A. Endocannabinoid signaling in the brain. Science 2002, 296:678-682.
51. Yu F., Zhong P., Liu X., Sun D., Gao H.Q., Liu Q.S. Metabotropic glutamate receptor I (mGluR1) antagonism impairs cocaine-induced conditioned place preference via inhibition of protein synthesis. Neuropsychopharmacology 2013, 38:1308-1321.
52. Zhong P., Wang W., Yu F., Nazari M., Liu X., Liu Q.S. Phosphodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity and conditioned place preference. Neuropsychopharmacology 2012, 37:2377-2387.